Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients ...
A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...
New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health ...
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback